<DOC>
	<DOCNO>NCT00379756</DOCNO>
	<brief_summary>This study consist four period ( screen , run-in , treatment , follow-up ) . A four-week treatment-free , run-in period subject make least four attempt intercourse four separate day least 50 % attempt must unsuccessful . During run-in subject use stopwatch measure time erection perceive hard enough penetration withdrawal partner 's vagina . Next 12 week treatment either placebo LEVITRA . Each subject require visit clinic 5 occasion period 4 month .</brief_summary>
	<brief_title>A Study Evaluating Vardenafil Compared Placebo Subjects With Erectile Dysfunction ( ED ) Dyslipidemia</brief_title>
	<detailed_description />
	<mesh_term>Dyslipidemias</mesh_term>
	<mesh_term>Erectile Dysfunction</mesh_term>
	<mesh_term>Vardenafil Dihydrochloride</mesh_term>
	<criteria>Inclusion criterion : Males ED six month , accord NIH Consensus Statement ( inability attain and/or maintain penile erection sufficient satisfactory sexual performance ) . Stable heterosexual relationship 6 month . The subject must make least four attempt sexual intercourse ( accord question subject diary : Was sexual activity initiate intention intercourse ? ) four separate day untreated baseline period . At least 50 % attempts period must unsuccessful , accord follow question subject diary [ least one question answer `` No '' ] : Were able achieve least erection ( enlargement penis ) ? Were able insert penis partner 's vagina ? Did erection last long enough successful intercourse ? Diagnosis dyslipidemia treat stable dose statin 6 month Visit 1 . IIEFEF domain score 25 denote mild severe ED Visit 2 . Documented , date , write Informed Consent . Exclusion criterion : Premature ejaculator &lt; 2 minute Any unstable medical , psychiatric , spinal cord injury , penile anatomical abnormality , substance abuse disorder MD feel subject able complete study . Low sexual desire . Prior prostatectomy surgery Severe chronic acute liver disease , history moderate severe liver impairment Clinically significant chronic hematological disease Bleeding disorder significant active peptic ulceration . Cardiovascular condition prevent sexual activity . History heart attack , stroke , lifethreatening arrhythmia within prior 6 month . hypotension hypertension rest . cancer within past 5 year . Use medication : nitrate nitric oxide donor , antiandrogens , oral injectable androgen , receive investigational drug ( include placebo ) within 30 day screen ( Visit 1 ) . Use treatment ED within 7 day screen include oral medication , vacuum device , constrictive device , injection urethral suppository . Subjects take follow potent inhibitor cytochrome P450 3A4 . Abnormal Laboratory Values : 1. serum total testosterone level &gt; 25 % low limit normal 2. serum creatinine &gt; 3.0 mg/dl . 3 . AST and/or ALT &gt; 3x upper limit normal .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>March 2011</verification_date>
	<keyword>Erectile dysfunction , impotence</keyword>
</DOC>